Navigation Links
Investigation in Medical Technology

Deer Farm Industry in Michigan Issues Statement on the Negative CWD Test Results at Kent County Deer Farm

... was contained. We remain hopeful that after the investigation of this incident, there will be a decisive ... anyone knows about this disease. As the investigation and the testing continues, the deer ... the department's willingness to bring the investigation to a swift conclusion and to ease the quarantine ...

Cytopia Concludes Phase I Oral Trial for Vascular-Disrupting Agent, CYT997

... well tolerated at biologically efficacious doses and is worthy of further investigation as a novel anticancer agent. "Cytopia has now demonstrated the broad ... dose for Phase II studies and pharmacokinetic assessment and a preliminary investigation of the anti-tumor properties of CYT997. Analysis of biological and ...

Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers

... subsequent allowance of the IND by the FDA and initiation of clinical investigation in the second quarter of 2008. In the preclinical program, ANA598 was ... to be used in combination with multiple other agents approved or under investigation for hepatitis C; (iii) the potential for once-daily or twice-daily oral ...

Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration

... AMD), a leading cause of blindness in adults. VIEW 2 (VEGF Trap-Eye: investigation of Efficacy and Safety in Wet AMD) will enroll approximately 1,200 ... in 2011. About VIEW 2 In the first year, the VIEW 2 (VEGF Trap-Eye: investigation of Efficacy and Safety in Wet AMD) study will evaluate the safety and ...

Society of Gynecologic Oncologists Issues White Paper on HPV Vaccine's Impact on Cervical Cancer Prevention

... of the current knowledge surrounding the impact and effectiveness of the HPV vaccine, and as a touchstone for areas where further research and investigation are needed to identify modifications in screening guidelines and intervention techniques." "The Future Strategies of Cervical Cancer ...

Prospective Clinical Advantages of Trabecular Metal(TM) Technology Highlighted in Comparative Study

... and consultants, our market share and our overall financial performance; the success of our quality initiatives; the outcome of the informal investigation by the U.S. Securities and Exchange Commission into Foreign Corrupt Practices Act matters announced in October 2007; price and product competition; ...

International Journal of Occupational and Environmental Health Features Discovery of Asbestos-Related Pain Origin from Scientists at the Karmanos Cancer Institute in Detroit

... the United States . Caring for nearly 6,000 new patients annually on a budget of $216 million, conducting more than 700 cancer-specific scientific investigation programs and clinical trials, the Karmanos Cancer Institute is among the nation's best cancer centers. Through the commitment of 1,000 staff, ...

Why Do African-Americans Fare Worse With Cancer? Access and Economics Are Only Part of the Story

... the Breast Care Center at the University of Michigan Comprehensive Cancer Center. "However, Dr. Albain's landmark study demonstrates that further investigation of race- or ethnicity-associated differences in primary tumor biology is also important." John Crowley, Ph.D., of the Southwest Oncology Group ...

Takeda Receives FDA Complete Response Letter for Alogliptin, an Investigational Treatment for Type 2 Diabetes

... Administration (FDA) regarding the Company's New Drug Application (NDA) for alogliptin, a selective dipeptidyl peptidase IV (DPP-4) inhibitor under investigation for the treatment of type 2 diabetes as an adjunct to diet and exercise. In recent months, the FDA and Takeda have been in discussions about ...

MJFF's Rapid Response Innovation Awards Hit Mid-2009 With Over $1 Million Funded in High-Risk/High-Reward Approaches to Parkinson's Disease

... to garner major additional funding to support the next stage of research, including clinical trials. These include D. James Surmeier, PhD's 2007-2008 investigation of approved high-blood pressure drug isradipine as a neuroprotective approach to PD, which is currently being tested with MJFF support in a Phase 2 ...

CoAxia, Inc. Announces $21.5M Series D Financing

... to provide sufficient funds for CoAxia to complete the SENTIS trial, and to submit results to the US FDA. In addition, the funds will allow further investigation of NeuroFlo in combination with a variety of stroke devices and drugs, and initiation of marketing. CoAxia President & CEO Andrew M. Weiss ...

The Lancet Publishes Direct Comparison Study Between Liraglutide and Exenatide

... had a statistically greater drop in A1C than those who received exenatide. The study compared liraglutide, a human GLP-1 analog, which is under investigation as a treatment for type 2 diabetes, to exenatide, the currently marketed GLP-1 receptor agonist. "Because of the differences in how the body ...

Researchers at the Karmanos Cancer Institute in Detroit Discover Feasibility of Chemotherapy Alternative

... United States . Caring for more than 6,000 new patients annually on a budget of $216 million, conducting more than 700 cancer-specific scientific investigation programs and clinical trials, the Karmanos Cancer Institute is among the nation's best cancer centers. Through the commitment of 1,000 staff, ...

Bayer Announces New Data on Novel Anti-cancer Compound BAY 73-4506

... (cell death) by directly targeting several oncogenic TK receptors. The clinical significance of these studies is not known and warrant further investigation in a broad spectrum of tumors. About Bayer HealthCare Pharmaceuticals Inc. Bayer HealthCare Pharmaceuticals Inc. is the U.S.-based ...

Scientists at The Karmanos Cancer Institute in Detroit Identify Potential New Target for Breast Cancer Therapy

... United States . Caring for more than 6,000 new patients annually on a budget of $216 million, conducting more than 700 cancer-specific scientific investigation programs and clinical trials, the Karmanos Cancer Institute is among the nation's best cancer centers. Through the commitment of 1,000 staff, ...

Celladon Provides MYDICAR(R) Program Update of First-In-Human Trial for Advanced Heart Failure at American Society of Gene Therapy Annual Meeting

... cells of these very sick patients," said Krisztina M. Zsebo, Ph.D., president and chief executive officer. "Our extensive preclinical and clinical investigation to understand the molecular basis of myocardial dysfunction, together with the evolution of safe and efficient gene transfer technology, has placed ...

Celladon Corporation Announces Presentation of First-in-Human Gene Transfer to Treat Heart Failure at the 12th Annual Meeting of the American Society of Gene Therapy

... adeno-associated viral vectors (AAV) are ideal for restoring SERCA2a enzyme production by means of cardiac muscle gene transfer. The path of investigation for MYDICAR(R) (AAV1/SERCA2a), from rodent studies to the ongoing Phase II clinical trial, has yielded valuable insights for the entire gene therapy ...

BioVex to Report Phase I/II Clinical Trial Results for the Front Line Treatment of Head and Neck Cancer With OncoVEX GM-CSF at the 2009 American Society of Clinical Oncology Meeting

... dose groups that remain disease free at up to 36 months from treatment is very encouraging. As a result, OncoVEX GM-CSF clearly warrants further investigation in this setting. " Philip Astley-Sparke, President & CEO, for BioVex said : "We are encouraged by these results which echo ...

Study Reported Tadalafil Taken Once Daily Improved Erectile Function in Men with ED and Sexual Quality of Life in Couples

... erectile or cardiovascular function; or 4) had found other phosphodiesterase-5 (PDE5) inhibitor treatments to be ineffective in treating ED. The 26 investigation sites were located in Austria, France, Germany, Mexico and the United States. In the first, four-week run-in phase of the study, men remained ED ...

Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen

... delivers overall sustained virologic response rates (SVR) of 50-60 percent. "These are exciting times in our fight against hepatitis C, and the investigation of the innovative oral treatment regimen in INFORM-1, if validated in further study, may radically change future treatment strategies in our patients ...

ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients

... New Drug Application (IND) to the U.S. Food and Drug Administration (FDA), subsequent allowance of the IND by the FDA and initiation of clinical investigation in the second quarter of 2008. In December 2008, Anadys announced that the FDA granted fast track designation to ANA598 for the treatment of chronic ...

Karmanos Cancer Institute Researchers Study New Drug Combinations to Treat Childhood Leukemia

... United States . Caring for more than 6,000 new patients annually on a budget of $216 million, conducting more than 700 cancer-specific scientific investigation programs and clinical trials, the Karmanos Cancer Institute is among the nation's best cancer centers. Through the commitment of 1,000 staff, ...

Hospital Care Varies Greatly for Children with Urinary Tract Infections

... length of stay and costs associated with clinical practice guidelines support their implementation." The study is the first large-scale investigation of variability in urinary tract infection (UTI) management and was published online March 26 in the Journal of Pediatrics . "It's astonishing ...

Karmanos Cancer Institute Researchers Present Breast Cancer Advancements at Conference

... United States . Caring for more than 6,000 new patients annually on a budget of $216 million, conducting more than 700 cancer-specific scientific investigation programs and clinical trials, the Karmanos Cancer Institute is among the nation's best cancer centers. Through the commitment of 1,000 staff, ...

Pivotal Clinical Data Published for the Only Laser Phototherapy Device Cleared by the FDA for Hair Growth

... evidence of efficacy and safety to the U.S. Food and Drug Administration will be published in the prestigious peer review journal, Clinical Drug investigation in May 2009 . Results of the clinical trial were a key factor in the clearance of the device for marketing in January 2007 for the promotion of ...

Nation's Laboratory Response Network Marks First Decade of Protecting Public Health

... in 1999 by the Association of Public Health Laboratories (APHL), the Centers for Disease Control and Prevention (CDC) and the Federal Bureau of investigation (FBI) to test for agents of bioterrorism, the Laboratory Response Network has evolved to become the nation's laboratory resource for response to ...

Impulse Dynamics Announces Pivotal Results at the American College of Cardiology Annual Meeting Late-Breaking Session

... ability. About the OPTIMIZER System The OPTIMIZER System is CE Marked and commercially available in Europe and is currently under clinical investigation at major U.S. research and academic facilities. It consists of a pulse generator and conventional pacing leads which deliver the therapy to the ...

Leader in Prostate Health Urges Prostate Cancer Screening in Face of Contradicting Data

... the rate of mortality by 20 percent. While the study designs differ, together they offer an opportunity for comparison. "More time and further investigation is needed to fully understand and evaluate the impact of prostate cancer screening on mortality before discontinuing screening practices," said Dr. ....

Alba Therapeutics Corporation Announces the Next Clinical Trial of Its Lead Compound, Larazotide Acetate and Promotions

... Madrid where he was elected Resident of the Year in Spain in 2001 (Sanities Prize). Dr. Leon was a postdoctoral fellow in the Laboratory of Clinical investigation (Mucosal Immunity Section) and in the Laboratory of Molecular Immunology (Mucosal Biology Section) of the National Institutes of Allergy and ...

New Study Suggests Cholesterol-Lowering Statins Reduce Severe Asthma Attacks that Result in Hospitalizations and Emergency Room Visits

... Solutions, Inc. (NYSE: MHS ) and Brigham and Women's Hospital, a teaching affiliate of Harvard Medical School . In the first and largest investigation of statin effects on clinical outcomes in humans with asthma, researchers found that among adult patients on inhaled corticosteroids, those also ...

Congressional 'Sting' Operation Uncovered By Coast IRB

... Coast IRB and its CEO, Daniel Dueber, ordered the immediate termination of the clinical trial, referred evidence to federal and state authorities for investigation and prosecution, and instituted measures to prevent a recurrence. Coast IRB is one of the largest independently owned IRB's and was founded in ...

Comparative Study Shows Significant Bone In-growth and Advanced Clinical Outcomes Using Zimmer's Trabecular Metal(TM) Technology

... and consultants, our market share and our overall financial performance; the success of our quality initiatives; the outcome of the informal investigation by the U.S. Securities and Exchange Commission into Foreign Corrupt Practices Act matters announced in October 2007; price and product competition; ...

Independent Data Monitoring Committee Recommends Resuming Enrollment of Non-Squamous NSCLC Patients in the Motesanib MONET1 Trial

... evaluated for its ability to inhibit angiogenesis by targeting vascular endothelial growth factor receptors 1, 2 and 3 (VEGFR1-3). It is also under investigation for its potential direct anti-tumor activity by targeting a family of proteins called tyrosine kinases, including platelet-derived growth factor ...

Sequoia Pharmaceuticals Presents Proof of Clinical Concept of SPI-452, a Novel Pharmacokinetic Enhancer

... an attribute that is in increasing demand in the treatment of HIV. These first-time-in-human and proof-of-clinical-concept data support the further investigation of SPI-452 and validate the Sequoia PKE development program. "In the HIV community and the clinical arena at large, there is a compelling need ...

Cancer Therapy & Research Center at The University of Texas Health Science Center and Oncolytics Biotech(R) Inc. Announce Multi-Trial Clinical Research Collaboration

... at UTHSCSA. "As Director of our Institute for Drug Development (IDD), I am pleased to specifically dedicate IDD resources toward the further rapid investigation of REOLYSIN(R), an agent which is proving itself in the clinic." "We're excited that an institution of this caliber is investing in additional ...

Kroger Recalls Peanut Butter Bakery Cookies and Select Cakes Due to Possible Health Risk

... may be associated with the peanut product recall by Peanut Corporation of America (PCA). The FDA has indicated that PCA is the focus of its investigation into Salmonella-related illnesses that may be linked to contaminated peanut products. For more information, please visit the FDA's website at ...

Kyowa Hakko Kirin Announces Development Policy for Anti-Parkinson's Disease Drug KW-6002 (Istradefylline)

... the Phase 2b study in Japan have recently become available and demonstrate the efficacy of KW-6002 compared with placebo, warranting further clinical investigation in Japan. For the development and commercialization of KW-6002 in overseas markets, is pursuing out-licensing opportunities. We believe ...

ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients

... New Drug Application (IND) to the U.S. Food and Drug Administration (FDA), subsequent allowance of the IND by the FDA and initiation of clinical investigation in the second quarter of 2008. In December 2008, Anadys announced that the FDA granted fast track designation to ANA598 for the treatment of chronic ...

Dacogen(R) (decitabine for injection) Data Presented on a Phase II Clinical Trial in Elderly Patients with Acute Myeloid Leukemia (AML)

... from MDS, or those who developed AML after previous treatment for cancer. The results presented at ASH provide additional support for the ongoing investigation of Dacogen(R) in a Phase III trial currently underway in elderly patients with AML. "We are enthusiastic about these new data presented at ...

Sosei Confirms the Safety of SD118 in Two Phase I Trials

... (ASX Code: NDL) and its wholly owned subsidiary NeuroSolutions Ltd under a Collaboration Agreement concluded in June 2006. SD118 was previously under investigation in Japan for a different indication. Now, following animal model studies conducted in Sosei's Drug Reprofiling Platform (DRP), it has ...
Other Contents
(Date:8/20/2014)... leaves, photosystem 1 (PS1) absorbs light and its ... carbon dioxide to biomass. Photovoltaic devices, mostly build ... but produce electricity. One approach for the development ... the semi-conductor with the isolated membrane protein complexes ... a highly stable PS1 from thermophilic cyanobacteria that ...
(Date:8/19/2014)... to decrease China,s increasing caesarean section rate, suggests a ... An International Journal of Obstetrics and Gynaecology (BJOG) . ... rates in the world. Of 16 million babies born ... exact rate is not known, the current Chinese language ... rates ranging from 36% to 58%. However, before the ...
(Date:8/19/2014)... This news release is available in German . ... power are inherently intermittent energy sources. If a large amount ... in the future, excess energy will have to be stored ... for. However, existing storage capacities are far from adequate for ... better technologies. One important focus lies on battery systems that ...
Breaking Biology News(10 mins):A semi-artificial leaf faster than 'natural' photosynthesis 2Is China's 50 percent cesarean section delivery rate too high? 2Is China's 50 percent cesarean section delivery rate too high? 3Asian inventions dominate energy storage systems 2Asian inventions dominate energy storage systems 3
(Date:8/20/2014)... Texas (PRWEB) August 20, 2014 One Call ... with the debut of ResCube, a fully-mobile wearable device that ... push of a button, 24 hours a day, 365 days ... around town, or cross country. It operates on the T-Mobile ... to be plugged in to work. , Like with the ...
(Date:8/20/2014)... 19, 2014 (HealthDay News) -- Taking the ... of dying from heart-related causes, a new study suggests. ... year, the findings require urgent confirmation, said the Danish ... actual risk is small and that guidelines for the ... more information is available. One heart expert wasn,t ...
(Date:8/20/2014)... chosen by Plymouth University to be an official charity ... to raise awareness of, and funding for, scientific research ... patients. , A range of events and activities organised ... and members of staff and students, as well as ... and volunteer. The involvement of the wider community across ...
(Date:8/20/2014)... 2014 The Workgroup for Electronic ... on the use of health IT to create ... agenda for its annual fall conference, WEDI-Con 2014: ... 2014 will take place at the HYATT Regency ... a diverse cross-section of payers, providers, government regulators, ...
(Date:8/20/2014)... Doctors at the University of Hong Kong claim to have ... by injecting them with a vaccine that changes their DNA. ... its website. Click here to read the full article ... of Microbiology created a vaccine using a protein called “programmed ... vaccine is designed to prevent mesothelioma cells from disabling the ...
Breaking Medicine News(10 mins):Health News:One Call Alert Introduces ResCube™, Smallest Mobile Medical Alert System on Market 2Health News:One Call Alert Introduces ResCube™, Smallest Mobile Medical Alert System on Market 3Health News:Antibiotic Might Raise Heart Risks for Some 2Health News:Plymouth University chooses Brain Tumour Research as official charity 2Health News:WEDI Releases Full Conference Agenda for Its Annual Fall Conference – WEDI-Con 2014 2Health News:WEDI Releases Full Conference Agenda for Its Annual Fall Conference – WEDI-Con 2014 3Health News:New Research Study Finds Vaccine Stops Mesothelioma in Lab Mice, According to Surviving Mesothelioma Website 2
Other TagsOther Tags